Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Update in sepsis 2012.

Russell JA, Walley KR.

Am J Respir Crit Care Med. 2013 Jun 15;187(12):1303-7. doi: 10.1164/rccm.201303-0567UP. Review.

PMID:
23767902
2.

Innovative therapies for sepsis.

Krishnagopalan S, Dellinger RP.

BioDrugs. 2001;15(10):645-54. Review.

PMID:
11604046
3.
4.

Translational research in the development of novel sepsis therapeutics: logical deductive reasoning or mission impossible?

Opal SM, Patrozou E.

Crit Care Med. 2009 Jan;37(1 Suppl):S10-5. doi: 10.1097/CCM.0b013e3181921497.

PMID:
19104207
5.

Early biomarker activity in severe sepsis and septic shock and a contemporary review of immunotherapy trials: not a time to give up, but to give it earlier.

Rivers EP, Jaehne AK, Nguyen HB, Papamatheakis DG, Singer D, Yang JJ, Brown S, Klausner H.

Shock. 2013 Feb;39(2):127-37. doi: 10.1097/SHK.0b013e31827dafa7. Review.

PMID:
23324881
6.

Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure.

Dhainaut JF, Shorr AF, Macias WL, Kollef MJ, Levi M, Reinhart K, Nelson DR.

Crit Care Med. 2005 Feb;33(2):341-8.

PMID:
15699837
7.

Sepsis research in the next millennium: concentrate on the software rather than the hardware.

Tjardes T, Neugebauer E.

Shock. 2002 Jan;17(1):1-8. Review.

PMID:
11795662
8.

Increasing the efficacy of anti-inflammatory agents used in the treatment of sepsis.

Minneci P, Deans K, Natanson C, Eichacker PQ.

Eur J Clin Microbiol Infect Dis. 2003 Jan;22(1):1-9. Epub 2003 Jan 28. Review.

PMID:
12582737
9.

Why have clinical trials in sepsis failed?

Marshall JC.

Trends Mol Med. 2014 Apr;20(4):195-203. doi: 10.1016/j.molmed.2014.01.007. Epub 2014 Feb 24.

PMID:
24581450
10.

Clinical trials for severe sepsis. Past failures, and future hopes.

Opal SM, Cross AS.

Infect Dis Clin North Am. 1999 Jun;13(2):285-97, vii. Review.

PMID:
10340167
11.
12.

Clinical trials of mediator-directed therapy in sepsis: what have we learned?

Marshall JC.

Intensive Care Med. 2000;26 Suppl 1:S75-83.

PMID:
10786962
13.

Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome.

Marshall JC.

Crit Care Med. 2001 Jul;29(7 Suppl):S99-106. Review.

PMID:
11445742
14.

Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.

Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM; Surviving Sepsis Campaign Management Guidelines Committee.

Crit Care Med. 2004 Mar;32(3):858-73. Review. Erratum in: Crit Care Med. 2004 Oct;32(10):2169-70. Crit Care Med. 2004 Jun;32(6):1448. Dosage error in article text.

PMID:
15090974
15.

Pathogenesis-oriented targets for adjunctive therapy.

Rigato O, Silva E, Salomao R.

Endocr Metab Immune Disord Drug Targets. 2006 Jun;6(2):193-200. Review.

PMID:
16787294
16.

Hemofiltration in sepsis and systemic inflammatory response syndrome: the role of dosing and timing.

Bouman CS, Oudemans-van Straaten HM, Schultz MJ, Vroom MB.

J Crit Care. 2007 Mar;22(1):1-12. Epub 2007 Jan 31. Review.

PMID:
17371737
17.

Sepsis, SIRS, and MODS: what's in a name?

Nathens AB, Marshall JC.

World J Surg. 1996 May;20(4):386-91. Review.

PMID:
8662129
18.

[Activated proteine C].

Montravers P, Quintard H, Piednoir P.

Ann Fr Anesth Reanim. 2006 Mar;25(3):270-4. Epub 2006 Jan 4. Review. French.

PMID:
16387470
19.

Advances in mesenchymal stem cell research in sepsis.

Wannemuehler TJ, Manukyan MC, Brewster BD, Rouch J, Poynter JA, Wang Y, Meldrum DR.

J Surg Res. 2012 Mar;173(1):113-26. doi: 10.1016/j.jss.2011.09.053. Epub 2011 Oct 24. Review.

PMID:
22225756
20.

Alternative outcome measures for pediatric clinical sepsis trials.

Curley MA, Zimmerman JJ.

Pediatr Crit Care Med. 2005 May;6(3 Suppl):S150-6. Review.

PMID:
15857550

Supplemental Content

Support Center